Prescription drug · NDA
Sernivo (Betamethasone dipropionate) NDC 68040-714
Betamethasone dipropionate .5 mg/g · Spray · Topical · Primus Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68040-714-08 | 68040071408 | 1 BOTTLE, SPRAY in 1 CARTON (68040-714-08) / 10 g in 1 BOTTLE, SPRAYMarketed from Jun 28, 2021 | |
| 68040-714-28 | 68040071428 | 1 BOTTLE, SPRAY in 1 CARTON (68040-714-28) / 120 g in 1 BOTTLE, SPRAYMarketed from Jun 28, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sernivo
- Generic name (nonproprietary)
- betamethasone dipropionate
- Active ingredients
- Betamethasone dipropionate — .5 mg/g
- Dosage form
- Spray
- Route
- Topical
- Labeler
- Primus Pharmaceuticals, Inc.NDC labeler code 68040
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208079
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 68040-714_8310ee9a-2de4-4246-a1ed-6fd23d041962SPL ID 8310ee9a-2de4-4246-a1ed-6fd23d041962SPL set ID b1b3d1b0-da9b-11eb-ad76-0800200c9a66RxCUI 1738536, 1738541UNII 826Y60901U
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468040071408followed by a unit qualifier and the quantityPackage 68040-0714-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
SERNIVO Spray is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. SERNIVO Spray is a corticosteroid indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 68040-714
- What is NDC 68040-714?
- 68040-714 is the product NDC for Sernivo (betamethasone dipropionate), Betamethasone dipropionate .5 mg/g spray, listed with the FDA by Primus Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sernivo (Betamethasone dipropionate).
- What is the active ingredient?
- Betamethasone dipropionate.
- Who is the labeler?
- Primus Pharmaceuticals, Inc., NDC labeler code 68040. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sernivo?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.